Sign inGet started

KILEY THOMAS

Insider CIK 1209330 · TSPT Director · CERE Director · GERN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CERE Ceres, Inc. A Award deriv2015-03-122015-03-165,833— $05,833SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-301,125— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-30583— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-30583— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-30158— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-30833— $00SEC↗
TSPT Transcept Pharmaceuticals D To issuer deriv2014-10-302014-10-30333— $00SEC↗
CERE Ceres, Inc. A Award deriv2014-03-072014-03-115,833— $05,833SEC↗
GERN GERON CORP D To issuer2013-05-222013-05-2453,156— $0171,911SEC↗
CERE Ceres, Inc. A Award deriv2013-03-212013-03-255,833— $05,833SEC↗
TSPT Transcept Pharmaceuticals A Award deriv2013-01-072013-01-0813,500— $013,500SEC↗
GERN GERON CORP D To issuer2012-12-312013-01-032,500— $0225,067SEC↗
CERE Ceres, Inc. M Exercise deriv2012-11-052012-11-0616,666— $00SEC↗
CERE Ceres, Inc. M Exercise2012-11-052012-11-0616,666$1.95 $32.5K16,666SEC↗
GERN GERON CORP A Award deriv2012-05-172012-05-1835,000— $035,000SEC↗
CERE Ceres, Inc. A Award deriv2012-05-032012-05-075,833— $05,833SEC↗
CERE Ceres, Inc. C Conversion deriv2012-02-272012-02-2815,385— $00SEC↗
CERE Ceres, Inc. C Conversion deriv2012-02-272012-02-280— $00SEC↗
CERE Ceres, Inc. C Conversion2012-02-272012-02-285,128— $05,128SEC↗
CERE Ceres, Inc. C Conversion2012-02-272012-02-289,615— $014,743SEC↗
CERE Ceres, Inc. J Other deriv2012-02-212012-02-220— $00SEC↗
TSPT Transcept Pharmaceuticals A Award deriv2012-01-242012-01-257,000— $07,000SEC↗